You have 9 free searches left this month | for more free features.

Condition

HER2-positive Breast Cancer (2)

Breast Cancer (1)

Locally Advanced or Metastatic Breast Cancer (1)

Metastatic Breast Cancer (1)

Overall Status

Not yet recruiting (3)

Recruiting (1)

Sign in for free

Phase

phase 2 (2)

phase 3 (2)

Sponsor

Hoffmann-La Roche (2)

German Breast Group (1)

Latin American Cooperative Oncology Group (1)

Collaborator

Roche Pharma AG (2)

Oncoclinicas (1)

Study Documents

Intervention Type

drug (4)

Funder Type

Industry (2)

Other (2)

Study Type

Interventional (4)

phesgo

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Metastatic Breast Cancer Trial (Inavolisib, Phesgo, Placebo)

Not yet recruiting

Metastatic Breast Cancer

Inavolisib
+4 more

(no location specified)

Jun 7, 2023

Locally Advanced or Metastatic Breast Cancer Trial in Worldwide (Phesgo, Giredestrant, Docetaxel)

Recruiting

Locally Advanced or Metastatic Breast Cancer

Phesgo
+5 more

Los Angeles, California
+21 more

Jul 25, 2022

Breast Cancer, HER2-positive Breast Cancer Trial in São Paulo (PHESGO)

Not yet recruiting

Breast Cancer
HER2-positive Breast Cancer

PHESGO

São Paulo, Brazil

Centro Paulista de Oncologia (Oncoclínicas)

Oct 3, 2023

HER2-positive Breast Cancer Trial (Inavolisib, PHESGO, Endocrine therapy)

Not yet recruiting

HER2-positive Breast Cancer

Inavolisib
+2 more

(no location specified)

Mar 23, 2022